SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,490.00    40.00 (0.90%)
Bid:
4,400.00
Ask:
4,580.00
Spread: 180.00 (4.091%)
Market Cap: £299.07m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Further re Acquisition

18 Jun 2009 12:54

RNS Number : 1287U
Judges Scientific PLC
18 June 2009
 

18 June 2009

JUDGES SCIENTIFIC plc

("Judges Scientific" or the "Company")

NEW BANK FACILITIES

FOLLOWING THE RECENTLY-ANNOUNCED ACQUISITION OF

QUORUM TECHNOLOGIES LIMITED

On 10 June 2009Judges Scientific plcthe parent company of a group that specialises in the design, manufacture and sale of scientific instruments, announced that it had completed the acquisition of the entire issued share capital of Quorum Technologies Limited ("Quorum" or the "Acquisition") for a total consideration of up to £1.5 million. The announcement stated that the Acquisition had been financed out of surplus funds, though the Bank of Scotland had agreed (subject to the finalisation of documentation) to make available a £4 million term loan Othis amount, £3 million would be drawn down to refinance both the acquisition and the Company's existing borrowing, of which approximately £1.7 million remained outstanding. The additional £1 million would be conditionally available to be drawn down in the event of further M&A activity. In addition, a £500,000 overdraft facility would continue to be available to the Company.

The Company now announces that the documentation in relation to the proposed Bank of Scotland facility has been completed as anticipated and that the £3 million term loan referred to above was drawn down on 18 June 2009.

Alex Hambro, Chairman of Judges Scientific, commented: "I am delighted that we have successfully completed the refinancing of our activities and of the Quorum acquisition. This leaves us with a prudent level of financial headroom to support our expanded range of activities and to pursue our strategy of enhancing earnings through the acquisition of niche businesses in our sector."

Enquiries:

David Cicurel, CEO, Judges Scientific: Tel: 01342 323 600

 

Pascal Keane, Shore Capital:     Tel: 020 7408 4090

Melvyn Marckus, Cardew Group:  Tel: 07775 896 491

Web sites:

Judges Scientific: www.judges.uk.com

Quorum: www.quorumtech.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FURCKFKPDBKDBAD
Date   Source Headline
11th Jun 20264:34 pmRNSDirector/PDMR Shareholding
1st Jun 20262:24 pmRNSTotal Voting Rights
26th May 20265:18 pmRNSPurchase of Ordinary Shares
20th May 20262:52 pmRNSResult of AGM
11th May 20263:10 pmRNSDirector/PDMR Shareholding
8th May 20265:05 pmRNSDirector/PDMR Shareholding
28th Apr 20267:00 amRNSNotice of AGM
22nd Apr 202611:53 amRNSConfirmation of Full Year Results
9th Apr 202611:14 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSUnaudited Preliminary Results
25th Mar 20267:00 amRNSNotice of Investor Presentation
10th Mar 20267:00 amRNSDirector/PDMR Shareholding
9th Feb 20261:49 pmRNSDirector/PDMR Shareholding
2nd Feb 20269:38 amRNSTotal Voting Rights
29th Jan 20263:31 pmRNSDirector/PDMR Shareholding
29th Jan 20267:00 amRNSGrant of Options
22nd Jan 20267:00 amRNSFull Year Trading Statement and Notice of Results
8th Jan 202611:18 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSBlocklisting Return
22nd Dec 20257:00 amRNSBlocklisting Return
9th Dec 202510:25 amRNSDirector/PDMR Shareholding
3rd Dec 20257:00 amRNSAcquisition of the minority shareholding in GdB
26th Nov 20257:00 amRNSBoard Succession
13th Nov 20255:05 pmRNSDirector/PDMR Shareholding
11th Nov 202512:08 pmRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNSTotal Voting Rights
20th Oct 20257:00 amRNSDirector/PDMR Shareholding
8th Oct 202511:43 amRNSDirector/PDMR Shareholding
1st Oct 202512:22 pmRNSTotal Voting Rights
18th Sep 20257:00 amRNSInterim Results
9th Sep 202511:42 amRNSDirector/PDMR Shareholding
21st Aug 20257:00 amRNSNotice of Investor Presentation
6th Aug 20255:46 pmRNSDirector/PDMR Shareholding
1st Aug 20257:00 amRNSTotal Voting Rights
30th Jul 20257:00 amRNSDirector/PDMR Shareholding
25th Jul 202510:07 amRNSDirector/PDMR Shareholding
24th Jul 20254:06 pmRNSDirector/PDMR Shareholding
24th Jul 20257:00 amRNSHalf Year Trading Update
8th Jul 20253:53 pmRNSDirector/PDMR Shareholding
1st Jul 20255:08 pmRNSTotal Voting Rights
1st Jul 20257:00 amRNSAppointment of Group Acquisitions Executive
23rd Jun 20257:00 amRNSBlocklisting Return
9th Jun 20251:37 pmRNSDirector/PDMR Shareholding
4th Jun 20255:03 pmRNSPurchase of Ordinary Shares
30th May 202512:06 pmRNSTotal Voting Rights
23rd May 202511:25 amRNSResult of AGM
13th May 20255:18 pmRNSPurchase of Ordinary Shares
8th May 20255:27 pmRNSDirector/PDMR Shareholding
28th Apr 20257:00 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.